BTS 2023 Guidelines for Pleural Disease – Pneumothorax

"This educational content has been informed by data from the article '[British Thoracic Society Guideline for pleural disease]' published in Thorax, available at Thorax Journal. Special thanks to BMJ Publishing Group for making this resource accessible for public education."

To enhance the flowchart based on the BTS 2023 Guidelines for Pleural Disease – Pneumothorax, the following updates can be included:

---

Step 1: Initial Assessment

• Is the patient symptomatic?
  • Symptoms include pain, breathlessness, or physiological compromise. Symptomatic patients often require more immediate intervention.

---

Step 2: High-Risk Characteristics

• Does the patient have high-risk characteristics?
  • The high-risk characteristics, now emphasized in the BTS 2023 guidelines, include:
    1. Hemodynamic compromise (suggestive of tension pneumothorax)
    2. Significant hypoxemia
    3. Bilateral pneumothorax
    4. Underlying lung disease
    5. Age ≥ 50 years with significant smoking history
    6. Hemopneumothorax
• If any of these characteristics are present, management involves:
  • Chest drain insertion (ICD)
  • Inpatient admission
  • Daily chest X-ray to monitor pneumothorax resolution
  • Removal of the chest drain when pneumothorax resolves, with outpatient follow-up post-discharge.

---

Step 3: Management Based on Risk Assessment and Intervention Safety

Conservative Management (Procedure Avoidance)

• Suitable for patients with minimal or no symptoms (no significant pain, breathlessness, or physiological compromise).
• For Primary Spontaneous Pneumothorax (PSP):
  • Outpatient monitoring every 2-4 days is recommended.
  • Advise the patient about treatment plans, potential side effects, and the need to return if symptoms worsen.
  • If the pneumothorax remains stable, outpatient follow-up continues every 2-4 weeks.
  • If symptoms worsen or the pneumothorax enlarges, admit the patient and insert a chest drain (ICD).

Rapid Symptom Relief (Needle Aspiration or Chest Drain)

• Needle aspiration should be considered based on the patient’s symptoms (e.g., significant breathlessness, pain) and clinical condition, regardless of the pneumothorax size.
• If needle aspiration is unsuccessful, proceed with chest drain insertion (ICD).
  • If successful, the patient can be discharged with outpatient follow-up in 2-4 weeks.
• Chest drain insertion is preferred if symptoms persist after needle aspiration or if the pneumothorax is not resolving on follow-up imaging.

Ambulatory Management (One-way Valve or Heimlich Valve)

• For stable patients, ambulatory management with a one-way valve can be used to relieve symptoms.
  • Regular outpatient follow-up is required every 2-3 days until the pneumothorax resolves, at which point the device is removed.

---

Primary Spontaneous Pneumothorax (PSP) Considerations

• For PSP, interventions focus on clinical stability and symptoms rather than pneumothorax size.
  • Conservative management remains an option for stable, asymptomatic patients.
  • Needle aspiration can be performed if the patient is symptomatic, typically when the pneumothorax size is 1-2 cm.
  • For larger pneumothoraces (>2 cm), chest drain insertion is recommended if intervention is required.

---

Secondary Spontaneous Pneumothorax (SSP) Considerations

• For SSP, which involves underlying lung disease, more aggressive interventions are required due to higher risks of complications.
  • Chest tube (ICD) insertion is indicated in all SSP cases, irrespective of pneumothorax size.

---

Chest Tube (ICD) Management

• Chest tube removal should be done during peak inspiration to avoid air re-entry, followed by application of an occlusive dressing.
• Suction Pressure: Standard suction pressure is –10 to –20 cm H2O, with the option to increase to –25 cm H2O for massive air leaks.
• Daily chest X-rays to monitor pneumothorax resolution and assess chest tube placement are mandatory.
• Persistent Air Leak: If air leaks persist beyond 3-5 days, consult with a cardiothoracic surgeon for possible thoracic surgery or use interventions like chemical pleurodesis or endobronchial valves.

---

Additional Considerations

Air Travel:

• Patients who have experienced a pneumothorax should avoid air travel for at least 7 days after the pneumothorax has fully resolved, which must be confirmed by a chest X-ray.
  • This recommendation is based on the significant changes in cabin pressure during flight, which can potentially lead to re-expansion of any residual pneumothorax or induce a new episode due to changes in atmospheric pressure.
  • After resolution, the risk of recurrence is significantly lower, but patients should still undergo a follow-up chest X-ray before clearance for travel.
  • In some cases, a thoracic surgeon or specialist may extend the recommended waiting period for individuals with complicated pneumothoraces or underlying lung conditions, depending on clinical stability.

Diving:

• Diving is strictly contraindicated for any patient with a history of pneumothorax unless they have undergone surgical intervention (such as thoracoscopic surgery or pleurodesis) to definitively resolve the pneumothorax.
  • This is due to the extreme pressure changes experienced while diving, which can significantly increase the risk of pneumothorax recurrence, even after the initial episode has resolved.
  • For divers, thoracic surgery or pleurodesis is often recommended as a preventative measure. Without this intervention, diving poses a high risk of recurrence and could result in a life-threatening situation underwater.
  • Patients who have undergone pleurodesis should wait for at least 1 year before resuming diving, with clearance required from a thoracic surgeon who must confirm the lung’s structural integrity via a follow-up chest CT or X-ray.

---

Intervention Considerations Based on Pneumothorax Size and Clinical Context:

• Pneumothorax of sufficient size for intervention depends on the clinical context, but generally, intervention is recommended if:
  • The pneumothorax is ≥ 2 cm laterally or apically on a chest X-ray.
  • Any size pneumothorax identified on CT scan that can be safely accessed with radiological support warrants consideration for intervention, particularly if symptoms are present.
• For smaller pneumothoraces (< 2 cm) in asymptomatic, stable patients, conservative management with monitoring and follow-up is considered, with the option for ambulatory care if pathways are available locally.

---

Monitoring and Review:

• During follow-up reviews, if there is evidence of an enlarging pneumothorax or if symptoms such as increasing pain or breathlessness develop, the management approach should escalate.
  • In such cases, chest drain insertion (ICD) should be considered, followed by admission for close monitoring, particularly if the patient is symptomatic or clinically unstable.
  • Monitoring includes repeated chest X-rays to track the pneumothorax’s progression and the patient's response to treatment.
• Success is defined as:
  • Improvement in symptoms (e.g., reduced breathlessness, pain relief).
  • Sustained improvement on chest X-ray (e.g., progressive resolution or no further expansion of the pneumothorax).

---

Talc Pleurodesis for High-Risk Patients:

• Talc pleurodesis may be considered even during the first episode of a pneumothorax in high-risk patients where the risk of recurrence is significant.
  • This approach is particularly relevant for patients with conditions like severe Chronic Obstructive Pulmonary Disease (COPD), where a repeat pneumothorax could have severe or life-threatening consequences.
  • Pleurodesis involves inducing an inflammatory reaction between the pleurae, which leads to fibrosis and adhesion, effectively obliterating the pleural space and preventing future air leaks.

---

This updated flowchart incorporates the BTS 2023 guidelines, shifting the focus from pneumothorax size to clinical symptoms, risk factors, and stability when determining the need for intervention, ensuring a more individualized, patient-centered approach.

---

Indications for Surgery in Pneumothorax

Surgery for pneumothorax is generally considered in cases where there is a high risk of recurrence or complications that cannot be managed conservatively. Here’s an overview of the indications for surgery in pneumothorax and the situations in which surgical intervention is required:

Indications for Surgery in Pneumothorax

1. Recurrent Pneumothorax
   • Spontaneous pneumothorax that recurs after initial management (e.g., chest tube drainage or conservative observation).
   • Bilateral pneumothorax or frequent episodes of pneumothorax despite prior interventions.
2. Persistent Air Leak
   • When there is a continuous air leak from the lung lasting more than 48-72 hours despite the use of an intercostal chest drain (ICD).
   • Surgery is necessary to close the air leak and prevent ongoing pneumothorax.
3. Large or Tension Pneumothorax
   • Patients with a large pneumothorax or those with a tension pneumothorax who do not respond well to chest drain insertion may require surgical intervention to prevent recurrence and to stabilize the condition.
4. Hemothorax or Hemopneumothorax
   • Pneumothorax associated with bleeding into the pleural space (hemothorax) requires surgical exploration to stop the bleeding and prevent complications like lung collapse.
5. Occupational Indications
   • High-risk occupations: Patients whose jobs put them at high risk if another pneumothorax occurs, such as pilots, divers, or anyone involved in professions where rapid changes in atmospheric pressure could lead to severe complications.
6. Failure of Conservative Management
   • In patients where conservative measures (such as chest tube insertion or aspiration) fail to fully resolve the pneumothorax or the lung fails to re-expand, surgery may be indicated to prevent future recurrences.
7. Secondary Pneumothorax with Underlying Lung Disease
   • In patients with severe underlying lung conditions like Chronic Obstructive Pulmonary Disease (COPD), a single episode of pneumothorax may be sufficient to consider surgery due to the increased risk of recurrence and the dangerous nature of subsequent episodes.

---

Types of Surgical Interventions

1. Video-Assisted Thoracoscopic Surgery (VATS)
   • Minimally invasive approach where small incisions are made, and a camera is inserted to visualize and repair the lung.
   • Procedures performed during VATS include:
     • Pleurodesis: Using substances like talc to irritate the pleura and prevent recurrence.
     • Blebectomy/Bullae Resection: Removal of the abnormal areas (blebs or bullae) responsible for air leaks.
     • Pleurectomy: Removal of part of the pleura to induce scarring and adhesion, preventing future pneumothorax.
2. Open Thoracotomy
   • More invasive surgery where a larger incision is made, usually reserved for patients where VATS is not feasible or when more extensive pleurectomy or lung resection is required.
3. Pleurodesis (Talc or Surgical)
   • Surgical pleurodesis is recommended for high-risk patients or those with persistent or recurrent pneumothorax. It can be done via thoracoscopy (using talc poudrage) or during VATS/open surgery (mechanical pleurodesis).
4. Surgical Decortication
   • This procedure involves removing the fibrous layer around the lung, which is typically used in complicated pneumothorax cases (e.g., associated with infection or malignancy) and in cases where the lung is unable to expand due to the presence of a fibrous peel.

---

Timing of Surgery

• Elective Surgery: Surgery may be planned for stable patients after recurrent pneumothorax to prevent future episodes.
• Emergency Surgery: This is indicated in cases of tension pneumothorax or persistent pneumothorax with significant air leaks or hemothorax that requires immediate surgical intervention.

---

Good Practice Points for Surgery

• Patient Selection: Only patients who are considered fit for surgery should undergo surgical interventions, especially for procedures like thoracotomy or VATS. For patients unfit for surgery, alternatives like pleurodesis with talc or an indwelling pleural catheter (IPC) can be considered.
• Individualized Decision Making: The decision to perform surgery should be based on the patient's clinical condition, risk of recurrence, and overall prognosis. Patient preference should also be considered, particularly in cases involving recurrent pneumothorax or malignant pleural effusion (MPE).

---

Conclusion

Surgery is a critical intervention in the management of pneumothorax, particularly for recurrent, persistent, or complicated cases. Procedures like VATS, blebectomy, pleurodesis, or decortication are used to ensure long-term resolution and prevent life-threatening complications. The decision to pursue surgery should be individualized based on patient condition and preferences.